Vaxcyte (PCVX) Exchange Rate Effect (2021 - 2026)
Vaxcyte (PCVX) posted quarterly Exchange Rate Effect of -$664000.0 for Q1 2026, down 156.66% year-over-year from $1.2 million in Q1 2025, and down 477.27% quarter-over-quarter from $176000.0 in Q4 2025.
Vaxcyte (PCVX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Vaxcyte (PCVX) has reported Exchange Rate Effect for 6 consecutive years, with -$664000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 156.66% year-over-year to -$664000.0; the TTM figure through Mar 2026 stood at $603000.0 (up 113.51% YoY), while the FY2025 annual figure was $2.4 million, up 472.54% from the prior year.
- Exchange Rate Effect fell to -$664000.0 in Q1 2026 per PCVX's latest filing, from $176000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $6.1 million in Q1 2024 and bottomed at -$7.7 million in Q4 2023.
- Historically, Exchange Rate Effect has averaged -$255764.7 across 5 years, with a median of $53000.0 in 2022.
- On a YoY basis, Exchange Rate Effect climbed as much as 26256.52% in 2024 and fell as far as 1707.69% in 2024.
- Vaxcyte's Exchange Rate Effect stood at $796000.0 in 2022, then slumped by 1065.08% to -$7.7 million in 2023, then jumped by 117.57% to $1.3 million in 2024, then slumped by 86.96% to $176000.0 in 2025, then slumped by 477.27% to -$664000.0 in 2026.
- Business Quant data shows PCVX's Exchange Rate Effect at -$664000.0 in Q1 2026, $176000.0 in Q4 2025, and $291000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Vaxcyte | 8.41 Bn | 8.41 Bn | - | 1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.40 Mn |
| Jun 30, 2026 | 1.40 Mn |
| Mar 31, 2026 | -664,000.00 |
| Mar 31, 2026 | -664,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -5.58 Mn |
| Sep 30, 2024 | -5.58 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Mar 31, 2024 | 6.06 Mn |
| Mar 31, 2024 | 6.06 Mn |